Clearmind Medicine Inc. (CMND) stock
CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Score 5/30
$3.45−0.73 (-17.52%)
Close on Nov 17, 2026Market cap $545.36KP/E –Yield –
Clearmind Medicine revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
No revenue figures for Clearmind Medicine
Clearmind Medicine has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?